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Levels of HBV DNA and not HBsAg are associated with biochemical flares after 
HBeAg seroconversion 
 
James Fung, Ching-lung Lai, Wai-kay Seto, Danny Ka-ho Wong, Man-fung Yuen 
The University of Hong Kong 
 
BACKGROUND: The role of HBsAg levels in predicting subsequent flares in chronic 
hepatitis B patients after HBeAg seroconversion is not known METHODS: Serum 
HBsAg and HBV DNA levels were determined in 224 CHB patients at 6-12 months after 
spontaneous HBeAg seroconversion. Serum HBV DNA levels were performed using 
Cobas Taqman assay. HBsAg titers were determined using Roche Elecsys HBsAg II 
assay (lower limit of detection 0.05 IU/mL). Patients were follow- up at 3-6 monthly 
intervals with routine liver biochemistry and viral serology performed. Flares was defined 
as ALT[29 upper limit of normal (ULN); the ULN for males and females was set at 30 
and 19 U/L respectively. RESULTS: The median age of HBeAg seroconversion was 37.5 
years with a median follow-up of 83 months. Eighty-nine (39.7%) had evidence of 
biochemical flare occurring at a median time of 27 months after HBeAg seroconversion. 
Patients with flares had older age compared to those without flares (39 vs 35 years 
respectively, p = 0.005). There was no significant difference in HBsAg levels of patients 
with flares compared to those without (3.6 logs vs 3.51 logs IU/mL respectively, p = 
0.946). In patients with flares, the HBV DNA was higher compared to those without 
flares (5.34 logs vs 4.60 logs copies/mL respectively, p = 0.007). Patients with HBV 
DNA[5 log copies/mL after HBeAg seroconversion had higher rates of subsequent flares 
compared to those with lower HBV DNA levels (p = 0.007 log rank). CONCLUSIONS: 
HBV DNA and not HBsAg levels after HBeAg seroconversion were associated with 
subsequent flares. 
